Teladoc Health Inc

Despite strong acceleration signaled by the active Parabola pattern within a Stage 2 advance, price is extended and overbought above key EMAs. With a bearish long-term trend anchoring structural polarity, we defer entry and stalk for pullbacks into the rising EMA support zone (9/20), where a hold would confirm continuation participation.

• ↑Integrated care revenue rose 2% YoY to $391M as membership hit 102.5M
• ↑BetterHelp insurance sessions at 14K/week deliver a $75M run rate, targeting $125M by 2026
• ↓Net loss of $0.36 per share and negative earnings yield highlight unprofitable operations